We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking TRAX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
TR

First Tracks Biotherapeutics, Inc. (TRAX) short interest & options flow

NASDAQ

TRAX heads into its November 12 earnings report with analysts raising targets, short sellers rebuilding positions, and options traders firmly biased toward calls. The most striking feature of the past few weeks is the speed with which the analyst community has re-rated this stock. Guggenheim lifted its target to $110 from $100 on November 4, keeping its Buy rating, the most recent…

$48.70-3.62% 1d+7.20% 1w+43.02% 1mClose: 12 Nov 2026
Short interest % of float
Dropping
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Market cap
$2.05B
Next earnings
3 Mar 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 13 Nov 2026

ORTEX chart of First Tracks Biotherapeutics, Inc. (TRAX) share price and short interest (% of free float), six months to November 12, 2026

TRAX news and analysis

RSS

No long-form analysis yet for TRAX. Pulse alerts and the live data picture are available on ORTEX.

Open TRAX on ORTEX →

Want the live picture for TRAX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TRAX — free to start on ORTEX.

Sign up for free →Open TRAX on ORTEX